MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    Determinant factor of tremor recurrence after Vim-FUS in ET and tremor-dominant PD

    E. Natera-Villalba, MA. Gorospe, GM. Díaz-Taveras, A. Jiménez-Huete, E. Salinas, A. Martín-Bastida, PM. Cortadi La-Villa, I. Avilés-Olmos, CA. Sánchez-Catasús, A. Arcadi, LH. González-Quarante, J. Guridi, MC. Rodríguez-Oroz (Pamplona, Spain)

    Objective: To identify clinical and technical predictors of recurrence of tremor in our own cohort of ET and TDPD patients undergoing Vim-FUS Background: Vim-FUS improves…
  • 2026 International Congress

    IncobotulinumtoxinA to Treat Sialorrhea in Parkinson’s Disease: a Real-life Study: 7-year Interim Results

    B. Bergmans, N. Winter, V. Schotte, N. Sys, E. van Massenhove, G. Pollet, M. van Zandijcke (Bruges, Belgium)

    Objective: We evaluate the long-term efficacy and safety of incobotulinumtoxinA injections in Parkinson’s disease (PD) patients suffering from sialorrhea (10 injection cycles (IC)). Background: Sialorrhea…
  • 2026 International Congress

    Digital Gait Biomarkers Reveal a Distinct Motor Prodrome Up to Five Years Before Parkinson’s Disease Diagnosis in the General Population

    P. Pelicioni, S. Waller, L. Chan, A. Krishnan, S. Lord, M. Brodie (Randwick, Australia)

    Objective: To assess whether novel digital gait biomarkers can predict incident Parkinson’s disease (PD) in a large cohort of middle-aged and older adults; and (ii)…
  • 2026 International Congress

    Structural Brain Measures Predict Cognitive Performance After Deep Brain Stimulation for Parkinson’s Disease

    J. Younce, A. Misra, T. Lee, M. Morgan, R. Kanser (Chapel Hill, USA)

    Objective: To determine whether pre-operative brain morphometry, combined with baseline neuropsychological performance, can predict post-operative cognitive performance in PD patients undergoing DBS using a sparse…
  • 2026 International Congress

    Plasma Fibrinogen Associates with Dopaminergic Neurodegeneration Independent of Peripheral Inflammation in drug-naïve Parkinson’s Disease

    T. Umehara, Y. Muraoka, Y. Nakayama, M. Mimori, M. Ozawa, T. Kitagawa, H. Matsuno, S. Omoto, R. Sengoku, Y. Iguchi (Tokyo, Japan)

    Objective: To investigate the association between plasma fibrinogen (Fib) levels, clinical features, and nigrostriatal dopaminergic neurodegeneration in drug-naïve patients with Parkinson’s disease (PD). Background: Fib…
  • 2026 International Congress

    Olfactory Dysfunction Across Neurodegenerative Disorders: A Prospective Cross-Sectional Comparison of Parkinson’s Disease, Alzheimer’s Disease and Idiopathic REM Sleep Behavior Disorder

    J. Einhaus, E. Kara, H. Jergas, C. Schedlich-Teufer, G. Tamgüney, G. Fink, M. Sommerauer, ö. Onur, M. Barbe (Cologne, Germany)

    Objective: To investigate whether olfactory function as measured by a standardized odor identification (Sniffin’ Stick) test, differs between patients with Parkinson's disease (PD), Alzheimer's disease…
  • 2026 International Congress

    Characteristics of Cortical Beta Bursts in Parkinson’s disease

    L. Witt, L. Chen, S. He, A. Pogosyan, L. Timmermann, H. Tan, D. Pedrosa, P. Loehrer (Marburg, Germany)

    Objective: ​​​​​​1.  Do patients with PD experience changes in cortical beta bursts in both the low and high β frequency bands?2.  Are bursts of different…
  • 2026 International Congress

    Impulse Control in Parkinson’s: β- and Muscle Burst Dynamics Reveal Distinct Effects of Pathology and Dopamine Medication

    A. Warden, D. Cruse, C. Mcallister, B. Wright, H. Macdonald (Birmingham, United Kingdom)

    Objective: To examine β- and muscle bursting patterns during impulse control in medicated and non-medicated people with Parkinson's disease (PwPD) to disentangle effects of disease…
  • 2026 International Congress

    Genetic risk factors reduce the risk of diabetes mellitus in Parkinsons disease

    EK. Tan, S. Chan, B. Tan, L. Tan, C. Chan (Singapore, Singapore)

    Objective: To determine if LRRK2 variants are able to reduce the diabetes associated risk in Parkinsons disease Background: Leucine-rich repeat kinase 2 (LRRK2) mutations are…
  • 2026 International Congress

    Fusion Learning with Attention-VAE Imputation for Mixed-Reality Multisensor Screening of Parkinson’s Disease

    J. Krzywdziak, J. Stępień, W. Szecówka, M. Dudek, M. żbik, M. Baran, N. Bozetine, J. Sikora, M. Wójcik-Pędziwiatr, M. Rudzińska-Bar, D. Hemmerling (Kraków, Poland)

    Objective: To evaluate whether a mixed-reality (MR) multisensor protocol combined with multimodal learning can discriminate Parkinson’s disease (PD) from healthy controls (HC) despite substantial missing…
  • « Previous Page
  • 1
  • …
  • 40
  • 41
  • 42
  • 43
  • 44
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley